| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $65K | -70.0% |
| R&D Expense | $54.2M | -28.3% |
| SG&A Expense | $32.7M | -11.7% |
| Operating Income | -$86.8M | +22.8% |
| Pre-tax Income | -$84.9M | +20.8% |
| Income Tax | $0 | — |
| Net Income | -$84.9M | +20.8% |
| EPS (Basic) | -$1.81 | +54.2% |
| EPS (Diluted) | -$1.81 | +54.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.3M | -32.7% |
| Short-term Investments | $14.2M | -49.7% |
| Accounts Receivable | $450 | -100.0% |
| Current Assets | $61.1M | -37.5% |
| Total Assets | $74.3M | -34.4% |
| Current Liabilities | $43.7M | +23.6% |
| Total Liabilities | $50.2M | +12.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$88.6M | +14.8% |
| Capital Expenditures | $286K | -41.4% |
| Investing Cash Flow | $14.0M | -86.5% |
| Financing Cash Flow | $53.1M | +3.1% |
| Free Cash Flow | -$88.9M | +15.0% |
| $24.1M |
| -64.8% |